Louise Wilkie | executive |
Alexander Macrae | executive |
Nathalie Dubois-Stringfellow | executive |
Nicole Germino | analyst |
Amy Pooler | executive |
Huidong Wang | analyst |
Yanan Zhu | analyst |
Maurice Raycroft | analyst |
Lisa Walter | analyst |
Good afternoon, and welcome to the Sangamo Therapeutics Second Quarter 2024 Teleconference Call. Please be advised that today's conference is being recorded. I would now like to turn the conference over to your speaker today, Louise Wilkie, Vice President of Investor Relations and Corporate Communications. Please go ahead.
Thank you. Good afternoon, everyone.